Clare completed her integrated Masters in Biochemistry at the University of Oxford in 2021, including a project on structure-guided vaccine design of blood-stage malaria vaccine immunogens with the Higgins lab.
Following this, she worked for two years in AstraZeneca’s Biologics Engineering department, on the development of novel antibody therapeutics.
Clare has now returned to the lab for her first rotation on the Wellcome Cellular Structural Biology DPhil program.
